Forbes November 29, 2024
Dr. Sai Balasubramanian, M.D., J.D.

Oura, widely known for its popular smart ring wearable device, announced last week that it has raised an additional $75 million in funding as a part of a Series D round, bringing its total valuation to nearly $5.2 billion. The funding was primarily spearheaded by Dexcom, a leading medical device company that focuses on diabetes diagnostics and glucose monitoring.

Oura has become incredibly popular in the last few years. The company, originally from Finland, launched its first wearable ring product nearly a decade ago to provide users with a better way to track sleep patterns. Since then, it has witnessed immense success and has continued to grow exponentially. The latest ring technology collects more than 20 biometrics to provide users...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Technology, Wearables
The future of cardiac monitoring: AI-powered wearables in practice
Continuous Glucose Monitors Predict Type 1 Diabetes Complications
AI in Smartwatches Enhances Health Event Prediction
Utilizing AI-Enabled Remote Wearables for Lifesaving Care
Where Does Diabetes Technology Stand In 2025?

Share This Article